HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiyotaka Okada Selected Research

monosodium(2- (6- hydroxynaphthalen- 2- yl)- 6- methylpyrimidin- 4- yloxy)acetate dihydrate

6/2002Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiyotaka Okada Research Topics

Disease

7Osteoporosis
01/2022 - 09/2013
6Fibrosis (Cirrhosis)
02/2013 - 07/2008
3Heterotopic Ossification (Ectopic Ossification)
09/2016 - 07/2013
3Thrombosis (Thrombus)
06/2002 - 01/2002
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2018 - 04/2014
2Bone Resorption
09/2017 - 09/2016
2Metabolic Bone Diseases (Osteopenia)
09/2017 - 06/2015
2Myositis Ossificans (Fibrodysplasia Ossificans Progressiva)
09/2016 - 06/2014
2Insulin Resistance
06/2015 - 05/2014
2Glucose Intolerance
06/2015 - 05/2014
2Hyperlipidemias (Hyperlipidemia)
06/2015 - 05/2014
2Hypoxia (Hypoxemia)
08/2014 - 07/2007
2Wounds and Injuries (Trauma)
09/2011 - 03/2009
2Venous Thrombosis (Deep-Vein Thrombosis)
06/2002 - 01/2002
1Osteoarthritis
11/2019
1Inflammation (Inflammations)
07/2014
1Obesity
05/2014
1Hypercholesterolemia
05/2014
1Vitamin D Deficiency
04/2014
1Nephritis
05/2013
1Ulcer
11/2012
1Corneal Ulcer
11/2012
1Corneal Perforation
11/2012
1Cataract (Cataracts)
04/2012
1Bone Diseases (Bone Disease)
03/2011
1Systemic Scleroderma (Systemic Sclerosis)
01/2010
1Vascular Remodeling
07/2008
1Ischemic Stroke
02/2008
1Starvation
06/2007
1Sneezing
06/2005
1Hypersensitivity (Allergy)
06/2005
1Melanoma (Melanoma, Malignant)
01/2004
1Carcinoma (Carcinomatosis)
01/2004
1Vascular System Injuries
11/2003
1Pulmonary Heart Disease (Cor Pulmonale)
10/2002
1Cardiovascular Diseases (Cardiovascular Disease)
10/2002
1Heart Failure
10/2002

Drug/Important Bio-Agent (IBA)

10Plasminogen Activator Inhibitor 1IBA
01/2019 - 02/2002
5GlucocorticoidsIBA
01/2022 - 06/2015
5Plasminogen Activators (Plasminogen Activator)IBA
03/2018 - 06/2005
5Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
07/2014 - 10/2002
5FibrinolysinFDA Link
11/2012 - 01/2002
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2014 - 10/2002
3Urokinase Plasminogen Activator ReceptorsIBA
11/2012 - 01/2004
2Matrix Metalloproteinases (MMPs)IBA
11/2019 - 12/2008
2Phosphotransferases (Kinase)IBA
09/2016 - 06/2014
2Activins (Activin)IBA
09/2016 - 06/2014
2Transforming Growth Factors (Transforming Growth Factor)IBA
09/2016 - 02/2013
2Glucose (Dextrose)FDA LinkGeneric
06/2015 - 05/2014
2Messenger RNA (mRNA)IBA
04/2014 - 04/2012
2Bleomycin (Blenoxane)FDA LinkGeneric
02/2013 - 01/2010
2PlasminogenIBA
11/2012 - 01/2002
2Transcription Factors (Transcription Factor)IBA
09/2011 - 03/2009
1InterleukinsIBA
11/2019
1Gonadal Steroid Hormones (Sex Hormones)IBA
11/2018
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
03/2018
1Alendronate (Alendronate Sodium)FDA LinkGeneric
09/2016
14- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA
09/2016
1collagen type I trimeric cross-linked peptideIBA
09/2016
1MineralsIBA
09/2016
1p38 Mitogen-Activated Protein KinasesIBA
09/2016
1Collagen Type I (Type I Collagen)IBA
09/2016
1SB 203580IBA
09/2016
1LipidsIBA
06/2015
1LipopolysaccharidesIBA
07/2014
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
06/2014
1Activin Receptors (Activin Receptor)IBA
06/2014
1Blood Glucose (Blood Sugar)IBA
05/2014
1Insulin (Novolin)FDA Link
05/2014
1Insulin-Like Growth Factor I (IGF-1)IBA
04/2014
1Streptozocin (Streptozotocin)FDA Link
04/2014
1OsteocalcinIBA
04/2014
1Vitamin DFDA LinkGeneric
04/2014
1Plasminogen InactivatorsIBA
09/2013
15- chloro- 2- (((2- (4- (diphenylmethyl)piperazin- 1- yl)- 2- oxoethoxy)acetyl)amino)benzoateIBA
05/2013
1CalciumIBA
02/2013
1Lipase (Acid Lipase)FDA Link
02/2013
1Phospholipases (Phospholipase)IBA
02/2013
1Calcium-Independent Phospholipases A2IBA
02/2013
1ProstaglandinsIBA
02/2013
1Prostaglandins FIBA
02/2013
1Interferon-gamma (Interferon, gamma)IBA
04/2012
1AntibodiesIBA
04/2012
1Complementary DNA (cDNA)IBA
04/2012
1jasmonic acid (jasmonate)IBA
09/2011
1Hormones (Hormone)IBA
09/2011
1Indoleacetic Acids (Auxin)IBA
09/2011
1ethyleneIBA
09/2011
1Transforming Growth Factor beta (TGF-beta)IBA
01/2010
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
07/2008
1Angiotensin IIIBA
07/2008
1Isoflurophate (DFP)FDA Link
06/2007
1Caspase 3 (Caspase-3)IBA
06/2007
1Interleukin-4 (Interleukin 4)IBA
06/2005
1Immunoglobulin E (IgE)IBA
06/2005
1Immunoglobulin G (IgG)IBA
06/2005
1Interleukin-5 (Interleukin 5)IBA
06/2005
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2004

Therapy/Procedure

4Therapeutics
03/2011 - 01/2002
1Ovariectomy (Oophorectomy)
01/2019